Table 1.
Clinical and biochemical characteristics of type 2 diabetic patients and non-diabetic control subjects
| Control (N = 51) |
NDR (N = 50) |
DR (N = 101) |
p | |
|---|---|---|---|---|
| Sex (m/f) | 30/21 | 24/26 | 54/47 | 0.552 |
| Age (years) | 61.1 ± 7.4 | 58.8 ± 8.9 | 60.7 ± 7.6 | 0.291 |
| BMI (kg/m2) | 22.5 ± 2.2 | 22.6 ± 2.4 | 23.6 ± 4.7 | 0.116 |
| Duration (years) | – | 8.5 ± 3.8 | 13.0 ± 3.3 | <0.001* |
| FPG (mmol/l) | – | 7.5 ± 1.8 | 9.3 ± 1.8 | <0.001* |
| HbAlc (%) | – | 8.8 ± 3.5 | 12.9 ± 3.2 | <0.001* |
Data are expressed as mean ± SD
DR type 2 diabetic patients with retinopathy, NDR type 2 diabetic patients without retinopathy, BMI Body mass index, FPG fasting plasma glucose; HbA1c glycated hemoglobin
* p < 0.05